Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 526 AL 540

The development of new therapeutics for Alzheimer's disease

Carter MD, Simms GA, Weaver DF.

Clin Pharmacol Ther. 2010 Oct;88(4):475-86. doi: 10.1038/clpt.2010.165. Epub 2010 Sep 1.

The role of tau kinases in Alzheimer's disease

Dolan PJ, Johnson GV.

Curr Opin Drug Discov Devel. 2010 Sep;13(5):595-603.

Alzheimer's secretases regulate voltage-gated sodium channels

Kovacs DM, Gersbacher MT, Kim DY.

Neurosci Lett. 2010 Dec 10;486(2):68-72. doi: 10.1016/j.neulet.2010.08.048. Epub 2010 Sep 15.

APOE and cholesterol homeostasis in Alzheimer's disease

Leduc V, Jasmin-Bélanger S, Poirier J.

Trends Mol Med. 2010 Oct;16(10):469-77. doi: 10.1016/j.molmed.2010.07.008.

The time has arrived to meet the challenge of Alzheimer's disease in Europe

Jones RW.

J Nutr Health Aging. 2010 Aug;14(7):523-4. doi: 10.1007/s12603-010-0262-z.

Evolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: findings from the IMPACT survey

Wortmann M, Andrieu S, Mackell J, Knox S.

J Nutr Health Aging. 2010 Aug;14(7):531-6. doi: 10.1007/s12603-010-0264-x.

The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease

Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT.

Curr Med Res Opin. 2010 Oct;26(10):2441-7. doi: 10.1185/03007995.2010.513849.

The use of profanity during letter fluency tasks in frontotemporal dementia and Alzheimer disease

Ringman JM, Kwon E, Flores DL, Rotko C, Mendez MF, Lu P.

Cogn Behav Neurol. 2010 Sep;23(3):159-64. doi: 10.1097/WNN.0b013e3181e11392.

Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease

Gunn AP, Masters CL, Cherny RA.

Int J Biochem Cell Biol. 2010 Dec;42(12):1915-8. doi: 10.1016/j.biocel.2010.08.015. Epub 2010 Sep 15.

Nodular bilateral amygdala degeneration in demented individuals

Hernandez Lain A, Lieberman AP, Pfannl R, Hedley-Whyte ET.

Acta Neuropathol. 2010 Nov;120(5):683-8. doi: 10.1007/s00401-010-0745-3. Epub 2010 Sep 14.

Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features

Giaccone G, Morbin M, Moda F, Botta M, Mazzoleni G, Uggetti A, Catania M, Moro ML, Redaelli V, Spagnoli A, Rossi RS, Salmona M, Di Fede G, Tagliavini F.

Acta Neuropathol. 2010 Dec;120(6):803-12. doi: 10.1007/s00401-010-0747-1. Epub 2010 Sep 15.

Contribution of temporal preparation and processing speed to simple reaction time in persons with Alzheimer's disease and mild cognitive impairment

Sylvain-Roy S, Bherer L, Belleville S.

Brain Cogn. 2010 Dec;74(3):255-61. doi: 10.1016/j.bandc.2010.08.004. Epub 2010 Sep 16.

Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene

Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM.

J Alzheimers Dis. 2010;22(1):307-13. doi: 10.3233/JAD-2010-100129.

B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review

Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B.

J Alzheimers Dis. 2010;22(1):205-24. doi: 10.3233/JAD-2010-090940.

Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control

Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM.

J Alzheimers Dis. 2010;22(1):17-36. doi: 10.3233/JAD-2010-091690.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias